Close this search box.

Non-profit biotech aims to revive stalled ultrarare therapies

ARTICLE | Product Development

Orphan Therapeutics Accelerator will pursue hybrid non-profit, commercial model 

By Steve Usdin, Washington Editor

March 20, 2024 10:03 PM UTC

A team of patient advocates and biotech veterans will soon announce the creation of the Orphan Therapeutics Accelerator, a non-profit biotech that will acquire and try to revive stalled ultrarare therapies.

The accelerator is an unusual response to a vexing problem.